Logo image of DOX.MI

DOXEE SPA (DOX.MI) Stock Fundamental Analysis

BIT:DOX - Euronext Milan - IT0005394413 - Common Stock - Currency: EUR

1.775  +0.01 (+0.85%)

Fundamental Rating

2

Taking everything into account, DOX scores 2 out of 10 in our fundamental rating. DOX was compared to 99 industry peers in the Software industry. Both the profitability and financial health of DOX have multiple concerns. While showing a medium growth rate, DOX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DOX has reported negative net income.
In the past year DOX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DOX reported negative net income in multiple years.
Each year in the past 5 years DOX had a positive operating cash flow.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

DOX has a worse Return On Assets (-8.41%) than 71.72% of its industry peers.
DOX's Return On Equity of -43.22% is on the low side compared to the rest of the industry. DOX is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
ROA -8.41%
ROE -43.22%
ROIC N/A
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

Looking at the Gross Margin, with a value of 71.32%, DOX is in line with its industry, outperforming 54.55% of the companies in the same industry.
In the last couple of years the Gross Margin of DOX has remained more or less at the same level.
DOX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

DOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOX has more shares outstanding than it did 1 year ago.
DOX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOX has been reduced compared to a year ago.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.36, we must say that DOX is in the distress zone and has some risk of bankruptcy.
DOX's Altman-Z score of 0.36 is on the low side compared to the rest of the industry. DOX is outperformed by 78.79% of its industry peers.
DOX has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
DOX's Debt to Equity ratio of 1.37 is on the low side compared to the rest of the industry. DOX is outperformed by 80.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACC8.37%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

DOX has a Current Ratio of 0.62. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
DOX has a Current ratio of 0.62. This is amonst the worse of the industry: DOX underperforms 80.81% of its industry peers.
DOX has a Quick Ratio of 0.62. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
DOX has a Quick ratio of 0.62. This is amonst the worse of the industry: DOX underperforms 80.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.84%, which is quite impressive.
Looking at the last year, DOX shows a small growth in Revenue. The Revenue has grown by 2.44% in the last year.
DOX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.31% yearly.
EPS 1Y (TTM)45.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.05%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%1.74%

3.2 Future

Based on estimates for the next years, DOX will show a very strong growth in Earnings Per Share. The EPS will grow by 62.70% on average per year.
DOX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.40% yearly.
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

DOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 87.87, the valuation of DOX can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as DOX.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, DOX is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 87.87
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than DOX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.19
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DOX's earnings are expected to grow with 62.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.7%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DOX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOXEE SPA

BIT:DOX (7/14/2025, 7:00:00 PM)

1.775

+0.01 (+0.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.39M
Analysts80
Price Target6.65 (274.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.43%
PT rev (3m)-3.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 87.87
P/S 0.77
P/FCF N/A
P/OCF 9.1
P/B 2.4
P/tB N/A
EV/EBITDA 13.19
EPS(TTM)-0.32
EYN/A
EPS(NY)0.02
Fwd EY1.14%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.2
OCFY10.99%
SpS2.3
BVpS0.74
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.41%
ROE -43.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.32%
FCFM N/A
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA 3.97
Cap/Depr 70.69%
Cap/Sales 13.87%
Interest Coverage N/A
Cash Conversion 76.19%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z 0.36
F-Score6
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)153.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.76%
Cap/Sales(5y)22.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.05%
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.44%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%1.74%
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4354.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.27%
OCF growth 3Y-10.06%
OCF growth 5Y-10.58%